BioSpace News Archive

Express Scripts Holding Company announced today its intention to release its 2018 third quarter financial results on Wednesday, October 31, 2018, after the market closes. Management will not be holding a conference call to review results.

AmpliPhi Biosciences Corporation today announced the closing of its previously announced underwritten public offering.

Casting messages widely throughout an electronic health record instead of using more focused direct messaging in diabetes care leads to more hospital visits and higher medical costs, according to a study published in the current issue of The American Journal of Managed Care®.

Collaboration that will streamline researchers’ access to biological insights by combining Nashville Biosciences’ BioVU® biobank with GENEWIZ’s next generation sequencing.

Lantheus Holdings, Inc. today announced that it will host a conference call at 4:30 p.m. ET on Tuesday, October 30, 2018, to discuss its financial and operating results for the third quarter of 2018.

Mobile medical clinics to provide disability exams to veterans in rural and underserved areas

New License Allows Leading Cannabinoid Biopharmaceutical Company to Advance Production of Clinical Trial Products

As part of the Administration’s ongoing efforts to strengthen cybersecurity in health care, the U.S. Food and Drug Administration and the U.S. Department of Homeland Security (DHS) announced a memorandum of agreement to implement a new framework for greater coordination and cooperation between the two agencies for addressing cybersecurity in medical devices.

Israeli startup further expands its ETERNA® advanced technology in the hearing aid industry for an innovative, portable, and easy-to-use wireless charging solution

Middlefield Group is pleased to announce the launch of a platform of Exchange-Traded Funds (“ETFs”) that will provide investors with professional active management within a cost-effective, investor-friendly structure.